Biomedical Catalyst 2023 Round 1: Industry-led R&D

Businesses can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges

Innovate UK, part of UK Research and Innovation, will invest up to £25 million to support UK registered businesses to develop innovative solutions to address significant health or healthcare challenges.

This industry-led research and development (R&D) competition will support projects that focus on:

• disease prevention and proactive management of health and chronic conditions
• earlier and better detection and diagnosis of disease, leading to better patient outcomes
• tailored treatments that either change the underlying disease or offer potential cures
• transforming the delivery of healthcare
• the development of digital health technologies

Projects can focus on health or a healthcare sector or discipline, including:

• biosciences
• advanced therapies (gene and cell therapies)
• diagnostic, medical technology and devices
• digital health
• independent living and wellbeing
• precision medicine
• preclinical technologies and drug target discovery
• therapeutic and medicine development

This list is not intended to be exhaustive. Innovate UK wants to fund a variety of projects across different markets, technologies, strands and themes.

This stream of the Biomedical Catalyst programme will support pre-market R&D projects. Applicants must be able to:

• demonstrate existing evidence of commercial and technical feasibility
• show how they will improve the competitiveness and productivity of at least one UK SME involved in the project

Read more about round 1 of the Biomedical Catalyst 2023.

To find out more about this competition, join an online briefing event on Thursday 12 January 2023.

First published 4 January 2023